Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H16FN5O2 |
| Molecular Weight | 365.361 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](OC1=CC2=CC(F)=CC=C2N=C1N)C3=C(C=CC(=O)N3)N4C=CC=N4
InChI
InChIKey=CLEFVPILGAPOTG-NSHDSACASA-N
InChI=1S/C19H16FN5O2/c1-11(18-15(5-6-17(26)24-18)25-8-2-7-22-25)27-16-10-12-9-13(20)3-4-14(12)23-19(16)21/h2-11H,1H3,(H2,21,23)(H,24,26)/t11-/m0/s1
| Molecular Formula | C19H16FN5O2 |
| Molecular Weight | 365.361 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:00:04 UTC 2023
by
admin
on
Sat Dec 16 18:00:04 UTC 2023
|
| Record UNII |
FXK42BP3GL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
766020
Created by
admin on Sat Dec 16 18:00:05 UTC 2023 , Edited by admin on Sat Dec 16 18:00:05 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
146591762
Created by
admin on Sat Dec 16 18:00:05 UTC 2023 , Edited by admin on Sat Dec 16 18:00:05 UTC 2023
|
PRIMARY | |||
|
2435610-93-6
Created by
admin on Sat Dec 16 18:00:05 UTC 2023 , Edited by admin on Sat Dec 16 18:00:05 UTC 2023
|
PRIMARY | |||
|
300000015140
Created by
admin on Sat Dec 16 18:00:05 UTC 2023 , Edited by admin on Sat Dec 16 18:00:05 UTC 2023
|
PRIMARY | |||
|
FXK42BP3GL
Created by
admin on Sat Dec 16 18:00:05 UTC 2023 , Edited by admin on Sat Dec 16 18:00:05 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->INHIBITOR OF AGGREGATION |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
